Chemours Co. Stock News

Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey PFAS settlement, freeing up future cash flow and reducing uncertainty. Balance sheet leverage remains high, but improving free cash flow in the second half should reduce net debt and support the cu...

Chemours (CC) Q2 EPS Jumps 53%

The Chemours Company (NYSE:CC ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Brandon Ontjes - Vice President of Investor Relations Denise M. Dignam - President, CEO & Director Shane W.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Second Quarter 2025 Results.

Chemours is at a cyclical low, presenting a buying opportunity ahead of expected 2Q25 revenue growth. Despite legacy risks and sub-par credit, Chemours' leadership in low-impact refrigerants and proprietary titanium technology sets it apart from competitors. Current market and analyst sentiment underestimates Chemours' potential, with forecasts showing strong EPS and EBITDA growth through 2026-...

Chemours , DuPont and Corteva said on Monday they have reached an agreement with the state of New Jersey in various litigation matters including PFAS chemicals and other state directives.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call.